Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.51 |
| ▸ | CSNK2A2 | P19784 | 3/20 | 0.50 |
| ▸ | CSNK2B | P67870 | 3/20 | 0.50 |
| ▸ | CSNK2A1 | P68400 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 4/20 | 0.49 |
| ▸ | RAB9A | P51151 | 4/20 | 0.49 |
| ▸ | F2 | P00734 | 1/20 | 0.46 |
| ▸ | F10 | P00742 | 1/20 | 0.46 |
| ▸ | PLG | P00747 | 1/20 | 0.46 |
| ▸ | PLAU | P00749 | 1/20 | 0.46 |
| ▸ | PLAT | P00750 | 1/20 | 0.46 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.46 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.46 |
| ▸ | PLCG2 | P16885 | 1/20 | 0.45 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.44 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5516544 | 1.00 | SMN1; SMN2 (0.51) | SMN1; SMN2CSNK2A2CSNK2BCSNK2A1NPC1 | |
| SCHEMBL2313102 | 0.84 | CSNK2A2 (0.49) | SMN1; SMN2CSNK2A2CSNK2BCSNK2A1NPC1 | |
| SCHEMBL2313095 | 0.84 | CSNK2A2 (0.49) | SMN1; SMN2CSNK2A2CSNK2BCSNK2A1NPC1 | |
| SCHEMBL4804018 | 0.75 | SMN1; SMN2 (0.63) | SMN1; SMN2CSNK2A2CSNK2BCSNK2A1NPC1 | |
| SCHEMBL12450700 | 0.75 | SMN1; SMN2 (0.63) | SMN1; SMN2CSNK2A2CSNK2BCSNK2A1NPC1 | |
| SCHEMBL4804024 | 0.75 | SMN1; SMN2 (0.63) | SMN1; SMN2CSNK2A2CSNK2BCSNK2A1NPC1 | |
| SCHEMBL10595203 | 0.73 | MEN1 (0.51) | SMN1; SMN2NPC1RAB9AF2DAPK3 | |
| SCHEMBL10595200 | 0.73 | MEN1 (0.51) | SMN1; SMN2NPC1RAB9AF2DAPK3 | |
| SCHEMBL24524106 | 0.72 | SMN1; SMN2 (0.63) | SMN1; SMN2CSNK2A2CSNK2BCSNK2A1NPC1 | |
| SCHEMBL21217197 | 0.72 | SMN1; SMN2 (0.68) | SMN1; SMN2CSNK2A2CSNK2BCSNK2A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070036722-A1 | Separation processes | RONGVED PAL | 2007-02-15 | — | — | US | disclosed |
| EP-1073716-B1 | IMPROVEMENTS IN OR RELATING TO SEPARATION PROCESSES | AMERSHAM HEALTH AS (NO) | 2004-04-28 | — | — | EP | disclosed |
| US-20030104359-A1 | Separation processes | NYCOMED IMAGING AS (NO) | 2003-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070036722-A1 | Separation processes | FUS, FGB, FAM83B | SMN1; SMN2 1765/4885CSNK2A2 1967/4885CSNK2B 1579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.